Article(id=1325223547639038023, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223510582370941, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2026.07.016, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1772380800000, receivedDateStr=2026-03-02, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793887515220, onlineDateStr=2026-11-05, pubDate=1783612800000, pubDateStr=2026-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793887515220, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793887515220, creator=13701087609, updateTime=1793887515220, updator=13701087609, issue=Issue{id=1325223510582370941, tenantId=1146029695717560320, journalId=1319690329412173987, year='2026', volume='47', issue='7', pageStart='709', pageEnd='830', issueExtLink='null', onlineDate='null', pubDate='1783612800000', pubDateStr='2026-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793887506384, creator='13701087609', updateTime=1793934747763, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325421655350194807, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223510582370941, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325421655350194808, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223510582370941, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=810, endPage=817, ext={EN=ArticleExt(id=1325223547890696264, articleId=1325223547639038023, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress of dihydroartemisinin in regulating tumor immune microenvironment and its application in anti-tumor combination therapy, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Dihydroartemisinin(DHA), as a first-line antimalarial drug, exhibits better pharmacokinetic characteristics compared to artemisinin, including higher absorption efficiency, broader tissue distribution, and lower toxicity. As the multi-target anti-tumor mechanism of DHA has gradually become clear, it has been regarded as a repurposed anti-tumor candidate with translational potential. DHA can inhibit the proliferation, invasion and metastasis of tumor cells, and induce apoptosis and autophagy. It can also regulate the tumor microenvironment(TME), inhibit angiogenesis, interfere with the functions of cancer-associated fibroblasts, and reshape the signal transmission between immune cells, thereby weakening tumor immunosuppression. This review summarized the specific roles of DHA in the TME, and demonstrated that DHA, as a potential anti-tumor drug, held significant clinical value.

, authors=Lili YU1a, Xiaomei HE1b, Tongfei LI2, Peng CHEN1c, Ping HUANG1b, Yingqiang LI3, *, authorsList=Lili YU, Xiaomei HE, Tongfei LI, Peng CHEN, Ping HUANG, Yingqiang LI, authorCompany=null, correspAuthors=Yingqiang LI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325223548175908937, articleId=1325223547639038023, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=双氢青蒿素调控肿瘤免疫微环境及在抗肿瘤联合治疗中的研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

双氢青蒿素(dihydroartemisinin,DHA)作为一线抗疟药物,较青蒿素表现出更佳的药代动力学特征,包括更高吸收效率、组织分布更广和毒性更低。随着DHA多靶点抗肿瘤作用机制逐渐明确,其已被视为具有转化潜力的再利用候选抗肿瘤药物。DHA可抑制肿瘤细胞增殖、侵袭和转移,并诱导凋亡、自噬等。其可调控肿瘤微环境(tumor microenvironment,TME),抑制血管生成、干扰肿瘤相关成纤维细胞功能以及重塑免疫细胞间信号传递,从而削弱肿瘤免疫抑制。该综述通过总结DHA在TME中的具体作用,阐述DHA作为一个潜在的抗肿瘤药物具有重要临床价值。

, authors=余丽丽1a, 贺晓梅1b, 李童斐2, 陈鹏1c, 黄平1b, 李应强3, *, authorsList=余丽丽, 贺晓梅, 李童斐, 陈鹏, 黄平, 李应强, authorCompany=null, correspAuthors=李应强, authorNote=

余丽丽,研究生硕士,研究方向:慢性病管理。

, correspAuthorsNote=
李应强,副主任医师,研究方向:肿瘤诊治。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=PVs09JItWzBv08ib4NU1UQ==, magXml=okm1ZuCvSKGcYqHdZNLZ2g==, pdfUrl=null, pdf=LxXxlqe4p3DJK2isHW0lYA==, pdfFileSize=1022699, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=8WeP2ubcL8M25Pe5mawylQ==, mapNumber=null, fund=null)}, authors=[Author(id=1325223550071734362, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223550176591964, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223550071734362, language=EN, stringName=Lili YU, firstName=Lili, middleName=null, lastName=YU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1a, address=1a.Department Outpatient, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223550252089437, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223550071734362, language=CN, stringName=余丽丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1a, address=1a.重庆中医药学院附属垫江医院门诊部,重庆 408300, bio={"content":"

余丽丽,研究生硕士,研究方向:慢性病管理。

"}, bioImg=null, bioContent=

余丽丽,研究生硕士,研究方向:慢性病管理。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223548440150090, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=1a., ext=[AuthorCompanyExt(id=1325223548448538699, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223548440150090, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1a.Department Outpatient, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China), AuthorCompanyExt(id=1325223548465315916, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223548440150090, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1a.重庆中医药学院附属垫江医院门诊部,重庆 408300)])]), Author(id=1325223550340169823, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223550440833121, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223550340169823, language=EN, stringName=Xiaomei HE, firstName=Xiaomei, middleName=null, lastName=HE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1b, address=1b.Department of Nursing, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223550520524898, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223550340169823, language=CN, stringName=贺晓梅, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1b, address=1b.重庆中医药学院附属垫江医院护理部,重庆 408300, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223549610360909, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=1b., ext=[AuthorCompanyExt(id=1325223549618749518, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549610360909, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1b.Department of Nursing, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China), AuthorCompanyExt(id=1325223549627138127, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549610360909, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1b.重庆中医药学院附属垫江医院护理部,重庆 408300)])]), Author(id=1325223550604410980, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223550726045798, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223550604410980, language=EN, stringName=Tongfei LI, firstName=Tongfei, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, Hubei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223550830903399, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223550604410980, language=CN, stringName=李童斐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.湖北医药学院基础医学院,湖北 十堰 442000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223549828464723, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=2., ext=[AuthorCompanyExt(id=1325223549836853332, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549828464723, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, Hubei Province, China), AuthorCompanyExt(id=1325223549845241941, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549828464723, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.湖北医药学院基础医学院,湖北 十堰 442000)])]), Author(id=1325223550939955305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223551036424299, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223550939955305, language=EN, stringName=Peng CHEN, firstName=Peng, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1c, address=1c.Department of Thoracic Cardiovascular and Breast Surgery, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223551145476204, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223550939955305, language=CN, stringName=陈鹏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1c, address=1c.重庆中医药学院附属垫江医院胸心血管乳腺外科,重庆 408300, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223549723607120, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=1c., ext=[AuthorCompanyExt(id=1325223549731995729, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549723607120, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1c.Department of Thoracic Cardiovascular and Breast Surgery, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China), AuthorCompanyExt(id=1325223549736190034, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549723607120, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1c.重庆中医药学院附属垫江医院胸心血管乳腺外科,重庆 408300)])]), Author(id=1325223551233556590, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223551330025584, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223551233556590, language=EN, stringName=Ping HUANG, firstName=Ping, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1b, address=1b.Department of Nursing, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223551422300273, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223551233556590, language=CN, stringName=黄平, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1b, address=1b.重庆中医药学院附属垫江医院护理部,重庆 408300, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223549610360909, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=1b., ext=[AuthorCompanyExt(id=1325223549618749518, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549610360909, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1b.Department of Nursing, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China), AuthorCompanyExt(id=1325223549627138127, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549610360909, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1b.重庆中医药学院附属垫江医院护理部,重庆 408300)])]), Author(id=1325223551522963571, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223551602655349, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223551522963571, language=EN, stringName=Yingqiang LI, firstName=Yingqiang, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Department of Oncology, Dianjiang General Hospital, Chongqing 408300, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223551682347126, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223551522963571, language=CN, stringName=李应强, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.重庆市垫江县人民医院肿瘤科,重庆 408300, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223549950099542, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=3., ext=[AuthorCompanyExt(id=1325223549954293847, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549950099542, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Oncology, Dianjiang General Hospital, Chongqing 408300, China), AuthorCompanyExt(id=1325223549966876760, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549950099542, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.重庆市垫江县人民医院肿瘤科,重庆 408300)])])], keywords=[Keyword(id=1325223551791399031, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, language=EN, orderNo=1, keyword=dihydroartemisinin), Keyword(id=1325223551862702200, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, language=EN, orderNo=2, keyword=tumor microenvironment), Keyword(id=1325223551934005369, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, language=EN, orderNo=3, keyword=angiogenesis), Keyword(id=1325223552026280058, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, language=EN, orderNo=4, keyword=cancer-associated fibroblast), Keyword(id=1325223552135331963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, language=CN, orderNo=1, keyword=双氢青蒿素), Keyword(id=1325223552235995260, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, language=CN, orderNo=2, keyword=肿瘤微环境), Keyword(id=1325223552315687037, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, language=CN, orderNo=3, keyword=血管生成), Keyword(id=1325223552412156030, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, language=CN, orderNo=4, keyword=肿瘤相关成纤维细胞)], refs=[Reference(id=1325223552672202880, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Hanboonkunupakarn B, White N J. Advances and roadblocks in the treatment of malaria[J]. Br J Clin Pharmacol, 2022,88(2):374-382., articleTitle=null, refAbstract=null), Reference(id=1325223552751894657, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Roh M E, Gutman J R, Murphy M, et al. Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy:a systematic review and individual participant data meta-analysis[J]. EClinicalMedicine, 2025, 83:103202., articleTitle=null, refAbstract=null), Reference(id=1325223552865140866, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Poupel F, Aghaei M, Movahedian A, et al. Dihydroartemisinin induces apoptosis in human bladder cancer cell lines through reactive oxygen species, mitochondrial membrane potential,and cytochrome c pathway[J]. Int J Prev Med, 2017, 8:78., articleTitle=null, refAbstract=null), Reference(id=1325223552978387075, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Wu Y, Chen D, Wang X, et al. Dihydroartemisinin targets GPX4 to induce autophagy-dependent ferroptosis and reduce radioresistance in triple-negative breast cancer[J]. Free Radic Biol Med, 2026, 246:35-50., articleTitle=null, refAbstract=null), Reference(id=1325223553062273156, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen J L, Yao G T. Herbal medicine dihydroartemisinin inhibits colorectal cancer by regulating PI3K/AKT signal-ing pathway[J]. J Oncol, 2023, 3(1):1080., articleTitle=null, refAbstract=null), Reference(id=1325223553171325061, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Fan H N, Zhu M Y, Peng S Q, et al. Dihydroartemisinin inhibits the growth and invasion of gastric cancer cells by regulating cyclin D1-CDK4-Rb signaling[J]. Pathol Res Pract, 2020, 216(2):152795., articleTitle=null, refAbstract=null), Reference(id=1325223553259405446, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Poupel F, Aghaei M, Movahedian A, et al. Dihydroartemisinin induces apoptosis in human bladder cancer cells lines through reactive oxygen species, mitochondrial membrane potential,and cytochrome C pathway[J]. Int J Prev Med, 2017, 8:78., articleTitle=null, refAbstract=null), Reference(id=1325223553339097223, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen Y, Mi Y, Zhang X, et al. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells[J]. J Exp Clin Cancer Res, 2019, 38(1):402., articleTitle=null, refAbstract=null), Reference(id=1325223553435566216, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Shi X, Wang L, Ren L, et al. Dihydroartemisinin,an antimalarial drug, induces absent in melanoma 2 inflammasome activation and autophagy in human hepatocellular carcinoma HepG2215 cells[J]. Phytother Res,2019, 33(5):1413-1425., articleTitle=null, refAbstract=null), Reference(id=1325223553540423817, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=T A S, Gupta S, Kiyawat P, et al. Tumor microenvironment in cancer biology:a comprehensive review of stromal, immune,and vascular components driving malignancy[J]. Cureus,2025, 17(12):e100320., articleTitle=null, refAbstract=null), Reference(id=1325223553657864330, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=余醒醒, 王鑫, 周怡, 等. 双氢青蒿素通过激活活性氧的产生诱导急性髓系白血病细胞凋亡[J]. 世界最新医学信息文摘, 2019, 19(32):112-113., articleTitle=null, refAbstract=null), Reference(id=1325223553762721931, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=从小凡, 陈腾, 李硕. 双氢青蒿素通过促进活性氧的产生增强鼻咽癌细胞对顺铂诱导凋亡的敏感性[J]. 南方医科大学学报, 2024, 44(8):1553-1560., articleTitle=null, refAbstract=null), Reference(id=1325223553863385228, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=唐恬, 曹祺, 夏庆杰. 双氢青蒿素抗肿瘤作用机制研究进展[J]. 肿瘤预防与治疗, 2021, 34(10):912-917., articleTitle=null, refAbstract=null), Reference(id=1325223553980825741, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Wen L, Chan B C, Qiu M H, et al. Artemisinin and its derivatives as potential anticancer agents[J]. Molecules,2024, 29(16):3886., articleTitle=null, refAbstract=null), Reference(id=1325223554089877646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=金昊儒, 赵俊杰, 何霄玥, 等. 青蒿素及其衍生物在抗肿瘤中诱导细胞死亡的研究进展[J]. 牡丹江医学院学报,2023, 44(2):130-132., articleTitle=null, refAbstract=null), Reference(id=1325223554177958031, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Dai X, Zhang X, Chen W, et al. Dihydroartemisinin:a potential natural anticancer drug[J]. Int J Biol Sci, 2021,17(2):603-622., articleTitle=null, refAbstract=null), Reference(id=1325223554349924496, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Ortmann B M. Hypoxia-inducible factor in cancer:from pathway regulation to therapeutic opportunity[J]. BMJ Oncol, 2024, 3(1):e000154., articleTitle=null, refAbstract=null), Reference(id=1325223554454782097, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Yu Y, Chen D, Wu T, et al. Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways[J]. Phytomedicine, 2022, 98:153932., articleTitle=null, refAbstract=null), Reference(id=1325223554572222610, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Bader S, Wilmers J, Ontikatze T, et al. Loss of pro-apoptotic Bax and Bak increases resistance to dihydroartemisinin-mediated cytotoxicity in normoxia but not in hypoxia in HCT116 colorectal cancer cells[J]. Free Radic Biol Med,2021, 174:157-170., articleTitle=null, refAbstract=null), Reference(id=1325223554681274515, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Gao P, Shen S, Li X, et al. Dihydroartemisinin inhibits the proliferation of leukemia cells K562 by suppressing PKM2 and GLUT1 mediated aerobic glycolysis[J]. Drug Des Devel Ther, 2020, 27(14):2091-2100., articleTitle=null, refAbstract=null), Reference(id=1325223554777743508, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Jin H, Jiang A Y, Wang H, et al. Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway[J].Mol Med Rep, 2017, 16(3):3475-3481., articleTitle=null, refAbstract=null), Reference(id=1325223554899378325, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Li Y, Sun H, Bai C, et al. Dihydroartemisinin inhibits tumor progression via blocking ROR1-induced STAT3 activation in non-small cell lung cancer[J]. Int Immunopharmacol, 2024,133:112157., articleTitle=null, refAbstract=null), Reference(id=1325223555016818838, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang W, Sun Y, Li X, et al. Dihydroartemisinin prevents distant metastasis of laryngeal carcinoma by inactivating STAT3 in cancer stem cells[J]. Med Sci Monit, 2020,16(26):e922348., articleTitle=null, refAbstract=null), Reference(id=1325223555142647959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Ji J, Cheng Z, Zhang J, et al. Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4-xCT pathway[J]. J Cell Mol Med, 2024, 28(8):e18335., articleTitle=null, refAbstract=null), Reference(id=1325223555247505560, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Ding X, Zhang Y, Liang J, et al. Dihydroartemisinin Potentiates VEGFR-TKIs antitumorigenic effect on osteosarcoma by regulating Loxl2/VEGFA expression and lipid metabolism pathway[J]. J Cancer, 2023, 14(5):809-820., articleTitle=null, refAbstract=null), Reference(id=1325223555335585945, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Guo Z, Jing X, Sun X, et al. Tumor angiogenesis and anti-angiogenic therapy[J]. Chin Med J(Engl), 2024, 137(17):2043-2051., articleTitle=null, refAbstract=null), Reference(id=1325223555419472026, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Li R, Yin H, Wang J, et al. Dihydroartemisinin alleviates skin fibrosis and endothelial dysfunction in systemic sclerosis[J].Clin Rheumatol, 2021, 40(10):4269-4277., articleTitle=null, refAbstract=null), Reference(id=1325223555536912539, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Li N, Zhang S, Luo Q, et al. The effect of dihydroartemisinin on the malignancy and epithelial-mesenchymal transition of gastric cancer cells[J]. Curr Pharm Biotechnol, 2019, 20(9):719-726., articleTitle=null, refAbstract=null), Reference(id=1325223555641770140, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Guo Q, Wang Q, Chen J, et al. Dihydroartemisinin regulated the MMP-mediated cellular microenvironment to alleviate rheumatoid arthritis[J]. Research(Wash D C), 2024, 7:0459., articleTitle=null, refAbstract=null), Reference(id=1325223555780182173, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Lorenc P, Sikorska A, Molenda S, et al. Physiological and tumor-associated angiogenesis:Key factors and therapy targeting VEGF/VEGFR pathway[J]. Biomed Pharmacother, 2024, 180:117585., articleTitle=null, refAbstract=null), Reference(id=1325223555885039774, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Rao Q, Yu H, Li R, et al. Dihydroartemisinin inhibits angiogenesis in breast cancer via regulating VEGF and MMP-2/-9[J]. Fundam Clin Pharmacol, 2024, 38(1):113-125., articleTitle=null, refAbstract=null), Reference(id=1325223555994091679, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Ma L, Zhao X, Liu Y, et al. Dihydroartemisinin attenuates osteoarthritis by inhibiting abnormal bone remodeling and angiogenesis in subchondral bone[J]. Int J Mol Med, 2021,47(3):4855., articleTitle=null, refAbstract=null), Reference(id=1325223556073783456, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Du W, Pang C, Xue Y, et al. Erratum:Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells[J]. Oncol Lett, 2021, 21(5):375., articleTitle=null, refAbstract=null), Reference(id=1325223556153475233, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang X, Khalil R A. Matrix metalloproteinases, vascular remodeling, and vascular disease[J]. Adv Pharmacol, 2018,81:241-330., articleTitle=null, refAbstract=null), Reference(id=1325223556237361314, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Cabral-Pacheco G A, Garza-Veloz I, Castruita-De La Rosa C, et al. The roles of matrix metalloproteinases and their inhibitors in human diseases[J]. Int J Mol Sci, 2020, 21(24):9739., articleTitle=null, refAbstract=null), Reference(id=1325223556325441699, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Xia Y, Shi C, Lu J, et al. Artemisinin and its derivatives from molecular mechanisms to clinical applications:new horizons beyond antimalarials[J]. Int J Mol Sci, 2025, 26(17):8409., articleTitle=null, refAbstract=null), Reference(id=1325223556409327780, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Fu H, Wu S, Shen H, et al. Dihydroartemisinin inhibits EphA2/PI3K/Akt pathway-mediated malignant behaviors and vasculogenic mimicry in glioma stem cells[J]. Heliyon,2025, 11(3):e42095., articleTitle=null, refAbstract=null), Reference(id=1325223556497408165, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=Shi H, Xiong L, Yan G, et al. Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis[J]. Front Mol Biosci, 2023, 10:1156062., articleTitle=null, refAbstract=null), Reference(id=1325223556568711334, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Racacho K J, Shiau Y P, Villa R, et al. The tumor immune microenvironment:implications for cancer immunotherapy,treatment strategies, and monitoring approaches[J]. Front Immunol, 2025, 16:1621812., articleTitle=null, refAbstract=null), Reference(id=1325223556652597415, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Mellman I, Chen D S, Powles T, et al. The cancer-immunity cycle:Indication, genotype, and immunotype[J]. Immunity,2023, 56(10):2188-2205., articleTitle=null, refAbstract=null), Reference(id=1325223556732289192, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen Y, Tao T, Liang Z, et al. Prednisone combined with dihydroartemisinin attenuates systemic lupus erythematosus by regulating M1/M2 balance through the MAPK signaling pathway[J]. Mol Immunol, 2024, 170:144-155., articleTitle=null, refAbstract=null), Reference(id=1325223556832952489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen R, Lu X, Li Z, et al. Dihydroartemisinin prevents progression and metastasis of head and neck squamous cell carcinoma by inhibiting polarization of macrophages in tumor microenvironment[J]. Onco Targets Ther, 2020, 13:3375-3387., articleTitle=null, refAbstract=null), Reference(id=1325223556916838570, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=Qi Y, Yan J, Huang X, et al. Targeting tumor-associated macrophage polarization with traditional Chinese medicine active ingredients:Dual reversal of chemoresistance and immunosuppression in tumor microenvironment[J].Pharmacol Res, 2025, 216:107788., articleTitle=null, refAbstract=null), Reference(id=1325223557021696171, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhou Z, Lei J, Fang J, et al. Dihydroartemisinin remodels tumor micro-environment and improves cancer immunotherapy through inhibiting cyclin-dependent kinases[J]. Int Immunopharmacol, 2024, 139:112637., articleTitle=null, refAbstract=null), Reference(id=1325223557101387948, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu J M, Jin Q X, Fujimoto M, et al. Dihydroartemisinin alleviates imiquimod-induced psoriasis-like skin lesion in mice involving modulation of IL-23/Th17 axis[J]. Front Pharmacol, 2021, 12:704481., articleTitle=null, refAbstract=null), Reference(id=1325223557185274029, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=Niu Y, Zhao Y, He J, et al. Dietary dihydroartemisinin supplementation alleviates intestinal inflammatory injury through TLR4/NOD/NF-κB signaling pathway in weaned piglets with intrauterine growth retardation[J]. Anim Nutr,2021, 7(3):667-678., articleTitle=null, refAbstract=null), Reference(id=1325223557285937326, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang H, Zhuo Y, Li D, et al. Dihydroartemisinin inhibits the growth of pancreatic cells by inducing ferroptosis and activating antitumor immunity[J]. Eur J Pharmacol, 2022,926:175028., articleTitle=null, refAbstract=null), Reference(id=1325223557394989231, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang T, Zhang Y, Jiang N, et al. Dihydroartemisinin regulates the immune system by promotion of CD8+ T lymphocytes and suppression of B cell responses[J]. Sci China Life Sci, 2020, 63(5):737-749., articleTitle=null, refAbstract=null), Reference(id=1325223557478875312, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=Yan S C, Wang Y J, Li Y J, et al. Dihydroartemisinin regulates the Th/Treg balance by inducing activated CD4+ T cell apoptosis via heme oxygenase-1 induction in mouse models of inflammatory bowel disease[J]. Molecules, 2019, 24(13):2475., articleTitle=null, refAbstract=null), Reference(id=1325223557587927217, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=Yu R, Jin L, Li F, et al. Dihydroartemisinin inhibits melanoma by regulating CTL/Treg anti-tumor immunity and STAT3-mediated apoptosis via IL-10 dependent manner[J]. J Dermatol Sci, 2020, 99(3):193-202., articleTitle=null, refAbstract=null), Reference(id=1325223557688590514, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=Shi X, Liao T, Chen Y, et al. Dihydroartemisinin inhibits follicular helper T and B cells:implications for systemic lupus erythematosus treatment[J]. Arch Pharm Res, 2024,47(7):632-644., articleTitle=null, refAbstract=null), Reference(id=1325223557801836723, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=Li Q, Jiang N, Zhang Y, et al. Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos[J]. Commun Biol,2023, 6(1):52., articleTitle=null, refAbstract=null), Reference(id=1325223557906694324, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=喻婉莹, 阚伟娟, 于鹏霞, 等. 青蒿素和二氢青蒿素的抗炎作用及机制[J]. 中国中药杂志, 2012, 37(17):2618-2621., articleTitle=null, refAbstract=null), Reference(id=1325223558003163317, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=Liang R, Chen W, Fan H, et al. Dihydroartemisinin prevents dextran sodium sulphate-induced colitisthrough inhibition of the activation of NLRP3 inflammasome and p38 MAPK signaling[J]. Int Immunopharmacol, 2020, 88:106949., articleTitle=null, refAbstract=null), Reference(id=1325223558099632310, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=Bu X, Wang L, Zhang Z, et al. Iron metabolism and the tumor microenvironment:A new perspective on cancer intervention and therapy(Review)[J]. Int J Mol Med, 2025, 55(3):39., articleTitle=null, refAbstract=null), Reference(id=1325223558259015863, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=Huang D, Xu D, Chen W, et al. Fe-MnO2 nanosheets loading dihydroartemisinin for ferroptosis and immunotherapy[J].Biomed Pharmacother, 2023, 161:114431., articleTitle=null, refAbstract=null), Reference(id=1325223558355484856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang H, Zhou F, Wang Y, et al. Eliminating radiation resistance of non-small cell lung cancer by dihydroartemisinin through abrogating immunity escaping and promoting radiation sensitivity by inhibiting PD-L1 expression[J].Front Oncol, 2020, 10:595466., articleTitle=null, refAbstract=null), Reference(id=1325223558464536761, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=Lin Z H, Xiang H Q, Yu Y W, et al. Dihydroartemisinin alleviates doxorubicin-induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy[J]. FASEB J,2024, 38(10):e23677., articleTitle=null, refAbstract=null), Reference(id=1325223558581977274, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[59], rfOrder=58, authorNames=null, journalName=null, refType=null, unstructuredReference=Trab B N, Ninh T T K, Do T T, et al. Hybrid nanoparticle for Co-delivering paclitaxel and dihydroartemisinin to exhibit synergic anticancer therapeutics[J]. Curr Cancer Drug Targets, 2024, 24(12):1250-1261., articleTitle=null, refAbstract=null), Reference(id=1325223558665863355, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[60], rfOrder=59, authorNames=null, journalName=null, refType=null, unstructuredReference=Rani K, Chand Sahu R, Chaudhuri A, et al. Exploring combinations of dihydroartemisinin for cancer therapy:a comprehensive review[J]. Biochem Biophys Res Commun,2025, 765:151854., articleTitle=null, refAbstract=null), Reference(id=1325223558766526652, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[61], rfOrder=60, authorNames=null, journalName=null, refType=null, unstructuredReference=Peng Q, Li S, Shi X, et al. Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting YAP1 expression to enhance anti-PD-1 efficacy[J].Phytother Res, 2023, 37(5):1740-1753., articleTitle=null, refAbstract=null), Reference(id=1325223558862995645, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[62], rfOrder=61, authorNames=null, journalName=null, refType=null, unstructuredReference=Han W, Duan X, Ni K, et al. Co-delivery of dihydroartemisinin and pyropheophorbide-iron elicits ferroptosis to potentiate cancer immunotherapy[J].Biomaterials, 2022, 280:121315., articleTitle=null, refAbstract=null), Reference(id=1325223558951076030, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[63], rfOrder=62, authorNames=null, journalName=null, refType=null, unstructuredReference=Shen Y, Zhang B, Su Y, et al. Iron promotes dihydroartemisinin cytotoxicity via ros production and blockade of autophagic flux via lysosomal damage in osteosarcoma[J]. Front Pharmacol, 2020, 11:444., articleTitle=null, refAbstract=null), Reference(id=1325223559022379199, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[64], rfOrder=63, authorNames=null, journalName=null, refType=null, unstructuredReference=Ni L, Zhu X, Zhao Q, et al. Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways[J]. Neoplasia, 2024, 51:100991., articleTitle=null, refAbstract=null)], funds=[Fund(id=1325223552550568063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, awardId=djkjxm2023shmskjcxyw010, language=CN, fundingSource=2023年垫江县科技局项目(djkjxm2023shmskjcxyw010), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1325223548440150090, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=1a., ext=[AuthorCompanyExt(id=1325223548448538699, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223548440150090, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1a.Department Outpatient, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China), AuthorCompanyExt(id=1325223548465315916, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223548440150090, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1a.重庆中医药学院附属垫江医院门诊部,重庆 408300)]), AuthorCompany(id=1325223549610360909, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=1b., ext=[AuthorCompanyExt(id=1325223549618749518, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549610360909, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1b.Department of Nursing, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China), AuthorCompanyExt(id=1325223549627138127, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549610360909, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1b.重庆中医药学院附属垫江医院护理部,重庆 408300)]), AuthorCompany(id=1325223549723607120, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=1c., ext=[AuthorCompanyExt(id=1325223549731995729, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549723607120, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1c.Department of Thoracic Cardiovascular and Breast Surgery, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China), AuthorCompanyExt(id=1325223549736190034, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549723607120, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1c.重庆中医药学院附属垫江医院胸心血管乳腺外科,重庆 408300)]), AuthorCompany(id=1325223549828464723, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=2., ext=[AuthorCompanyExt(id=1325223549836853332, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549828464723, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, Hubei Province, China), AuthorCompanyExt(id=1325223549845241941, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549828464723, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.湖北医药学院基础医学院,湖北 十堰 442000)]), AuthorCompany(id=1325223549950099542, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=3., ext=[AuthorCompanyExt(id=1325223549954293847, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549950099542, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Oncology, Dianjiang General Hospital, Chongqing 408300, China), AuthorCompanyExt(id=1325223549966876760, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549950099542, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.重庆市垫江县人民医院肿瘤科,重庆 408300)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.07.016, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.07.016, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2026.07.016, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2026.07.016, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1783612800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
双氢青蒿素调控肿瘤免疫微环境及在抗肿瘤联合治疗中的研究进展
余丽丽 1a , 贺晓梅 1b , 李童斐 2 , 陈鹏 1c , 黄平 1b , 李应强 3, *
世界临床药物 | 综述评论 2026,47(7): 810-817
收起
收藏切换
世界临床药物 |综述评论 2026 , 47 (7) : 810 -817
双氢青蒿素调控肿瘤免疫微环境及在抗肿瘤联合治疗中的研究进展
全屏
[Author(id=1325223550071734362, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223550176591964, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223550071734362, language=EN, stringName=Lili YU, firstName=Lili, middleName=null, lastName=YU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1a, address=1a.Department Outpatient, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223550252089437, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223550071734362, language=CN, stringName=余丽丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1a, address=1a.重庆中医药学院附属垫江医院门诊部,重庆 408300, bio={"content":"

余丽丽,研究生硕士,研究方向:慢性病管理。

"}, bioImg=null, bioContent=

余丽丽,研究生硕士,研究方向:慢性病管理。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223548440150090, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=1a., ext=[AuthorCompanyExt(id=1325223548448538699, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223548440150090, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1a.Department Outpatient, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China), AuthorCompanyExt(id=1325223548465315916, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223548440150090, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1a.重庆中医药学院附属垫江医院门诊部,重庆 408300)])]), Author(id=1325223550340169823, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223550440833121, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223550340169823, language=EN, stringName=Xiaomei HE, firstName=Xiaomei, middleName=null, lastName=HE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1b, address=1b.Department of Nursing, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223550520524898, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223550340169823, language=CN, stringName=贺晓梅, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1b, address=1b.重庆中医药学院附属垫江医院护理部,重庆 408300, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223549610360909, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=1b., ext=[AuthorCompanyExt(id=1325223549618749518, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549610360909, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1b.Department of Nursing, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China), AuthorCompanyExt(id=1325223549627138127, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549610360909, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1b.重庆中医药学院附属垫江医院护理部,重庆 408300)])]), Author(id=1325223550604410980, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223550726045798, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223550604410980, language=EN, stringName=Tongfei LI, firstName=Tongfei, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, Hubei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223550830903399, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223550604410980, language=CN, stringName=李童斐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.湖北医药学院基础医学院,湖北 十堰 442000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223549828464723, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=2., ext=[AuthorCompanyExt(id=1325223549836853332, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549828464723, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, Hubei Province, China), AuthorCompanyExt(id=1325223549845241941, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549828464723, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.湖北医药学院基础医学院,湖北 十堰 442000)])]), Author(id=1325223550939955305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223551036424299, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223550939955305, language=EN, stringName=Peng CHEN, firstName=Peng, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1c, address=1c.Department of Thoracic Cardiovascular and Breast Surgery, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223551145476204, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223550939955305, language=CN, stringName=陈鹏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1c, address=1c.重庆中医药学院附属垫江医院胸心血管乳腺外科,重庆 408300, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223549723607120, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=1c., ext=[AuthorCompanyExt(id=1325223549731995729, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549723607120, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1c.Department of Thoracic Cardiovascular and Breast Surgery, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China), AuthorCompanyExt(id=1325223549736190034, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549723607120, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1c.重庆中医药学院附属垫江医院胸心血管乳腺外科,重庆 408300)])]), Author(id=1325223551233556590, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223551330025584, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223551233556590, language=EN, stringName=Ping HUANG, firstName=Ping, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1b, address=1b.Department of Nursing, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223551422300273, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223551233556590, language=CN, stringName=黄平, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1b, address=1b.重庆中医药学院附属垫江医院护理部,重庆 408300, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223549610360909, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=1b., ext=[AuthorCompanyExt(id=1325223549618749518, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549610360909, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1b.Department of Nursing, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China), AuthorCompanyExt(id=1325223549627138127, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549610360909, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1b.重庆中医药学院附属垫江医院护理部,重庆 408300)])]), Author(id=1325223551522963571, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223551602655349, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223551522963571, language=EN, stringName=Yingqiang LI, firstName=Yingqiang, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Department of Oncology, Dianjiang General Hospital, Chongqing 408300, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223551682347126, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, authorId=1325223551522963571, language=CN, stringName=李应强, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.重庆市垫江县人民医院肿瘤科,重庆 408300, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223549950099542, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, xref=3., ext=[AuthorCompanyExt(id=1325223549954293847, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549950099542, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Oncology, Dianjiang General Hospital, Chongqing 408300, China), AuthorCompanyExt(id=1325223549966876760, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223547639038023, companyId=1325223549950099542, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.重庆市垫江县人民医院肿瘤科,重庆 408300)])])]
余丽丽1a, 贺晓梅1b, 李童斐2, 陈鹏1c, 黄平1b, 李应强3, *
作者信息
  • 1a.重庆中医药学院附属垫江医院门诊部,重庆 408300
  • 1b.重庆中医药学院附属垫江医院护理部,重庆 408300
  • 1c.重庆中医药学院附属垫江医院胸心血管乳腺外科,重庆 408300
  • 2.湖北医药学院基础医学院,湖北 十堰 442000
  • 3.重庆市垫江县人民医院肿瘤科,重庆 408300
通讯作者:
李应强,副主任医师,研究方向:肿瘤诊治。
作者简介:

余丽丽,研究生硕士,研究方向:慢性病管理。

Research progress of dihydroartemisinin in regulating tumor immune microenvironment and its application in anti-tumor combination therapy
Lili YU1a, Xiaomei HE1b, Tongfei LI2, Peng CHEN1c, Ping HUANG1b, Yingqiang LI3, *
Affiliations
  • 1a.Department Outpatient, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China
  • 1b.Department of Nursing, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China
  • 1c.Department of Thoracic Cardiovascular and Breast Surgery, Dianjiang Hospital Affiliated to Chongqing University of Traditional Chinese Medicine, Chongqing 408300, China
  • 2.School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, Hubei Province, China
  • 3.Department of Oncology, Dianjiang General Hospital, Chongqing 408300, China
出版时间: 2026-07-10 doi: 10.13683/j.wph.2026.07.016
文章导航
收藏切换

双氢青蒿素(dihydroartemisinin,DHA)作为一线抗疟药物,较青蒿素表现出更佳的药代动力学特征,包括更高吸收效率、组织分布更广和毒性更低。随着DHA多靶点抗肿瘤作用机制逐渐明确,其已被视为具有转化潜力的再利用候选抗肿瘤药物。DHA可抑制肿瘤细胞增殖、侵袭和转移,并诱导凋亡、自噬等。其可调控肿瘤微环境(tumor microenvironment,TME),抑制血管生成、干扰肿瘤相关成纤维细胞功能以及重塑免疫细胞间信号传递,从而削弱肿瘤免疫抑制。该综述通过总结DHA在TME中的具体作用,阐述DHA作为一个潜在的抗肿瘤药物具有重要临床价值。

双氢青蒿素  /  肿瘤微环境  /  血管生成  /  肿瘤相关成纤维细胞

Dihydroartemisinin(DHA), as a first-line antimalarial drug, exhibits better pharmacokinetic characteristics compared to artemisinin, including higher absorption efficiency, broader tissue distribution, and lower toxicity. As the multi-target anti-tumor mechanism of DHA has gradually become clear, it has been regarded as a repurposed anti-tumor candidate with translational potential. DHA can inhibit the proliferation, invasion and metastasis of tumor cells, and induce apoptosis and autophagy. It can also regulate the tumor microenvironment(TME), inhibit angiogenesis, interfere with the functions of cancer-associated fibroblasts, and reshape the signal transmission between immune cells, thereby weakening tumor immunosuppression. This review summarized the specific roles of DHA in the TME, and demonstrated that DHA, as a potential anti-tumor drug, held significant clinical value.

dihydroartemisinin  /  tumor microenvironment  /  angiogenesis  /  cancer-associated fibroblast
余丽丽, 贺晓梅, 李童斐, 陈鹏, 黄平, 李应强. 双氢青蒿素调控肿瘤免疫微环境及在抗肿瘤联合治疗中的研究进展. 世界临床药物, 2026 , 47 (7) : 810 -817 . DOI: 10.13683/j.wph.2026.07.016
Lili YU, Xiaomei HE, Tongfei LI, Peng CHEN, Ping HUANG, Yingqiang LI. Research progress of dihydroartemisinin in regulating tumor immune microenvironment and its application in anti-tumor combination therapy[J]. World Clinical Drug, 2026 , 47 (7) : 810 -817 . DOI: 10.13683/j.wph.2026.07.016
  • 2023年垫江县科技局项目(djkjxm2023shmskjcxyw010)
参考文献 引证文献
排序方式:
[1]
Hanboonkunupakarn B, White N J. Advances and roadblocks in the treatment of malaria[J]. Br J Clin Pharmacol, 2022,88(2):374-382.
[2]
Roh M E, Gutman J R, Murphy M, et al. Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy:a systematic review and individual participant data meta-analysis[J]. EClinicalMedicine, 2025, 83:103202.
[3]
Poupel F, Aghaei M, Movahedian A, et al. Dihydroartemisinin induces apoptosis in human bladder cancer cell lines through reactive oxygen species, mitochondrial membrane potential,and cytochrome c pathway[J]. Int J Prev Med, 2017, 8:78.
[4]
Wu Y, Chen D, Wang X, et al. Dihydroartemisinin targets GPX4 to induce autophagy-dependent ferroptosis and reduce radioresistance in triple-negative breast cancer[J]. Free Radic Biol Med, 2026, 246:35-50.
[5]
Chen J L, Yao G T. Herbal medicine dihydroartemisinin inhibits colorectal cancer by regulating PI3K/AKT signal-ing pathway[J]. J Oncol, 2023, 3(1):1080.
[6]
Fan H N, Zhu M Y, Peng S Q, et al. Dihydroartemisinin inhibits the growth and invasion of gastric cancer cells by regulating cyclin D1-CDK4-Rb signaling[J]. Pathol Res Pract, 2020, 216(2):152795.
[7]
Poupel F, Aghaei M, Movahedian A, et al. Dihydroartemisinin induces apoptosis in human bladder cancer cells lines through reactive oxygen species, mitochondrial membrane potential,and cytochrome C pathway[J]. Int J Prev Med, 2017, 8:78.
[8]
Chen Y, Mi Y, Zhang X, et al. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells[J]. J Exp Clin Cancer Res, 2019, 38(1):402.
[9]
Shi X, Wang L, Ren L, et al. Dihydroartemisinin,an antimalarial drug, induces absent in melanoma 2 inflammasome activation and autophagy in human hepatocellular carcinoma HepG2215 cells[J]. Phytother Res,2019, 33(5):1413-1425.
[10]
T A S, Gupta S, Kiyawat P, et al. Tumor microenvironment in cancer biology:a comprehensive review of stromal, immune,and vascular components driving malignancy[J]. Cureus,2025, 17(12):e100320.
[11]
余醒醒, 王鑫, 周怡, 等. 双氢青蒿素通过激活活性氧的产生诱导急性髓系白血病细胞凋亡[J]. 世界最新医学信息文摘, 2019, 19(32):112-113.
[12]
从小凡, 陈腾, 李硕. 双氢青蒿素通过促进活性氧的产生增强鼻咽癌细胞对顺铂诱导凋亡的敏感性[J]. 南方医科大学学报, 2024, 44(8):1553-1560.
[13]
唐恬, 曹祺, 夏庆杰. 双氢青蒿素抗肿瘤作用机制研究进展[J]. 肿瘤预防与治疗, 2021, 34(10):912-917.
[14]
Wen L, Chan B C, Qiu M H, et al. Artemisinin and its derivatives as potential anticancer agents[J]. Molecules,2024, 29(16):3886.
[15]
金昊儒, 赵俊杰, 何霄玥, 等. 青蒿素及其衍生物在抗肿瘤中诱导细胞死亡的研究进展[J]. 牡丹江医学院学报,2023, 44(2):130-132.
[16]
Dai X, Zhang X, Chen W, et al. Dihydroartemisinin:a potential natural anticancer drug[J]. Int J Biol Sci, 2021,17(2):603-622.
[17]
Ortmann B M. Hypoxia-inducible factor in cancer:from pathway regulation to therapeutic opportunity[J]. BMJ Oncol, 2024, 3(1):e000154.
[18]
Yu Y, Chen D, Wu T, et al. Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways[J]. Phytomedicine, 2022, 98:153932.
[19]
Bader S, Wilmers J, Ontikatze T, et al. Loss of pro-apoptotic Bax and Bak increases resistance to dihydroartemisinin-mediated cytotoxicity in normoxia but not in hypoxia in HCT116 colorectal cancer cells[J]. Free Radic Biol Med,2021, 174:157-170.
[20]
Gao P, Shen S, Li X, et al. Dihydroartemisinin inhibits the proliferation of leukemia cells K562 by suppressing PKM2 and GLUT1 mediated aerobic glycolysis[J]. Drug Des Devel Ther, 2020, 27(14):2091-2100.
[21]
Jin H, Jiang A Y, Wang H, et al. Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway[J].Mol Med Rep, 2017, 16(3):3475-3481.
[22]
Li Y, Sun H, Bai C, et al. Dihydroartemisinin inhibits tumor progression via blocking ROR1-induced STAT3 activation in non-small cell lung cancer[J]. Int Immunopharmacol, 2024,133:112157.
[23]
Wang W, Sun Y, Li X, et al. Dihydroartemisinin prevents distant metastasis of laryngeal carcinoma by inactivating STAT3 in cancer stem cells[J]. Med Sci Monit, 2020,16(26):e922348.
[24]
Ji J, Cheng Z, Zhang J, et al. Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4-xCT pathway[J]. J Cell Mol Med, 2024, 28(8):e18335.
[25]
Ding X, Zhang Y, Liang J, et al. Dihydroartemisinin Potentiates VEGFR-TKIs antitumorigenic effect on osteosarcoma by regulating Loxl2/VEGFA expression and lipid metabolism pathway[J]. J Cancer, 2023, 14(5):809-820.
[26]
Guo Z, Jing X, Sun X, et al. Tumor angiogenesis and anti-angiogenic therapy[J]. Chin Med J(Engl), 2024, 137(17):2043-2051.
[27]
Li R, Yin H, Wang J, et al. Dihydroartemisinin alleviates skin fibrosis and endothelial dysfunction in systemic sclerosis[J].Clin Rheumatol, 2021, 40(10):4269-4277.
[28]
Li N, Zhang S, Luo Q, et al. The effect of dihydroartemisinin on the malignancy and epithelial-mesenchymal transition of gastric cancer cells[J]. Curr Pharm Biotechnol, 2019, 20(9):719-726.
[29]
Guo Q, Wang Q, Chen J, et al. Dihydroartemisinin regulated the MMP-mediated cellular microenvironment to alleviate rheumatoid arthritis[J]. Research(Wash D C), 2024, 7:0459.
[30]
Lorenc P, Sikorska A, Molenda S, et al. Physiological and tumor-associated angiogenesis:Key factors and therapy targeting VEGF/VEGFR pathway[J]. Biomed Pharmacother, 2024, 180:117585.
[31]
Rao Q, Yu H, Li R, et al. Dihydroartemisinin inhibits angiogenesis in breast cancer via regulating VEGF and MMP-2/-9[J]. Fundam Clin Pharmacol, 2024, 38(1):113-125.
[32]
Ma L, Zhao X, Liu Y, et al. Dihydroartemisinin attenuates osteoarthritis by inhibiting abnormal bone remodeling and angiogenesis in subchondral bone[J]. Int J Mol Med, 2021,47(3):4855.
[33]
Du W, Pang C, Xue Y, et al. Erratum:Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells[J]. Oncol Lett, 2021, 21(5):375.
[34]
Wang X, Khalil R A. Matrix metalloproteinases, vascular remodeling, and vascular disease[J]. Adv Pharmacol, 2018,81:241-330.
[35]
Cabral-Pacheco G A, Garza-Veloz I, Castruita-De La Rosa C, et al. The roles of matrix metalloproteinases and their inhibitors in human diseases[J]. Int J Mol Sci, 2020, 21(24):9739.
[36]
Xia Y, Shi C, Lu J, et al. Artemisinin and its derivatives from molecular mechanisms to clinical applications:new horizons beyond antimalarials[J]. Int J Mol Sci, 2025, 26(17):8409.
[37]
Fu H, Wu S, Shen H, et al. Dihydroartemisinin inhibits EphA2/PI3K/Akt pathway-mediated malignant behaviors and vasculogenic mimicry in glioma stem cells[J]. Heliyon,2025, 11(3):e42095.
[38]
Shi H, Xiong L, Yan G, et al. Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis[J]. Front Mol Biosci, 2023, 10:1156062.
[39]
Racacho K J, Shiau Y P, Villa R, et al. The tumor immune microenvironment:implications for cancer immunotherapy,treatment strategies, and monitoring approaches[J]. Front Immunol, 2025, 16:1621812.
[40]
Mellman I, Chen D S, Powles T, et al. The cancer-immunity cycle:Indication, genotype, and immunotype[J]. Immunity,2023, 56(10):2188-2205.
[41]
Chen Y, Tao T, Liang Z, et al. Prednisone combined with dihydroartemisinin attenuates systemic lupus erythematosus by regulating M1/M2 balance through the MAPK signaling pathway[J]. Mol Immunol, 2024, 170:144-155.
[42]
Chen R, Lu X, Li Z, et al. Dihydroartemisinin prevents progression and metastasis of head and neck squamous cell carcinoma by inhibiting polarization of macrophages in tumor microenvironment[J]. Onco Targets Ther, 2020, 13:3375-3387.
[43]
Qi Y, Yan J, Huang X, et al. Targeting tumor-associated macrophage polarization with traditional Chinese medicine active ingredients:Dual reversal of chemoresistance and immunosuppression in tumor microenvironment[J].Pharmacol Res, 2025, 216:107788.
[44]
Zhou Z, Lei J, Fang J, et al. Dihydroartemisinin remodels tumor micro-environment and improves cancer immunotherapy through inhibiting cyclin-dependent kinases[J]. Int Immunopharmacol, 2024, 139:112637.
[45]
Liu J M, Jin Q X, Fujimoto M, et al. Dihydroartemisinin alleviates imiquimod-induced psoriasis-like skin lesion in mice involving modulation of IL-23/Th17 axis[J]. Front Pharmacol, 2021, 12:704481.
[46]
Niu Y, Zhao Y, He J, et al. Dietary dihydroartemisinin supplementation alleviates intestinal inflammatory injury through TLR4/NOD/NF-κB signaling pathway in weaned piglets with intrauterine growth retardation[J]. Anim Nutr,2021, 7(3):667-678.
[47]
Zhang H, Zhuo Y, Li D, et al. Dihydroartemisinin inhibits the growth of pancreatic cells by inducing ferroptosis and activating antitumor immunity[J]. Eur J Pharmacol, 2022,926:175028.
[48]
Zhang T, Zhang Y, Jiang N, et al. Dihydroartemisinin regulates the immune system by promotion of CD8+ T lymphocytes and suppression of B cell responses[J]. Sci China Life Sci, 2020, 63(5):737-749.
[49]
Yan S C, Wang Y J, Li Y J, et al. Dihydroartemisinin regulates the Th/Treg balance by inducing activated CD4+ T cell apoptosis via heme oxygenase-1 induction in mouse models of inflammatory bowel disease[J]. Molecules, 2019, 24(13):2475.
[50]
Yu R, Jin L, Li F, et al. Dihydroartemisinin inhibits melanoma by regulating CTL/Treg anti-tumor immunity and STAT3-mediated apoptosis via IL-10 dependent manner[J]. J Dermatol Sci, 2020, 99(3):193-202.
[51]
Shi X, Liao T, Chen Y, et al. Dihydroartemisinin inhibits follicular helper T and B cells:implications for systemic lupus erythematosus treatment[J]. Arch Pharm Res, 2024,47(7):632-644.
[52]
Li Q, Jiang N, Zhang Y, et al. Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos[J]. Commun Biol,2023, 6(1):52.
[53]
喻婉莹, 阚伟娟, 于鹏霞, 等. 青蒿素和二氢青蒿素的抗炎作用及机制[J]. 中国中药杂志, 2012, 37(17):2618-2621.
[54]
Liang R, Chen W, Fan H, et al. Dihydroartemisinin prevents dextran sodium sulphate-induced colitisthrough inhibition of the activation of NLRP3 inflammasome and p38 MAPK signaling[J]. Int Immunopharmacol, 2020, 88:106949.
[55]
Bu X, Wang L, Zhang Z, et al. Iron metabolism and the tumor microenvironment:A new perspective on cancer intervention and therapy(Review)[J]. Int J Mol Med, 2025, 55(3):39.
[56]
Huang D, Xu D, Chen W, et al. Fe-MnO2 nanosheets loading dihydroartemisinin for ferroptosis and immunotherapy[J].Biomed Pharmacother, 2023, 161:114431.
[57]
Zhang H, Zhou F, Wang Y, et al. Eliminating radiation resistance of non-small cell lung cancer by dihydroartemisinin through abrogating immunity escaping and promoting radiation sensitivity by inhibiting PD-L1 expression[J].Front Oncol, 2020, 10:595466.
[58]
Lin Z H, Xiang H Q, Yu Y W, et al. Dihydroartemisinin alleviates doxorubicin-induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy[J]. FASEB J,2024, 38(10):e23677.
[59]
Trab B N, Ninh T T K, Do T T, et al. Hybrid nanoparticle for Co-delivering paclitaxel and dihydroartemisinin to exhibit synergic anticancer therapeutics[J]. Curr Cancer Drug Targets, 2024, 24(12):1250-1261.
[60]
Rani K, Chand Sahu R, Chaudhuri A, et al. Exploring combinations of dihydroartemisinin for cancer therapy:a comprehensive review[J]. Biochem Biophys Res Commun,2025, 765:151854.
[61]
Peng Q, Li S, Shi X, et al. Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting YAP1 expression to enhance anti-PD-1 efficacy[J].Phytother Res, 2023, 37(5):1740-1753.
[62]
Han W, Duan X, Ni K, et al. Co-delivery of dihydroartemisinin and pyropheophorbide-iron elicits ferroptosis to potentiate cancer immunotherapy[J].Biomaterials, 2022, 280:121315.
[63]
Shen Y, Zhang B, Su Y, et al. Iron promotes dihydroartemisinin cytotoxicity via ros production and blockade of autophagic flux via lysosomal damage in osteosarcoma[J]. Front Pharmacol, 2020, 11:444.
[64]
Ni L, Zhu X, Zhao Q, et al. Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways[J]. Neoplasia, 2024, 51:100991.
2026年第47卷第7期
65
8
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2026.07.016
  • 接收时间:2026-03-02
  • 首发时间:2026-11-05
  • 出版时间:2026-07-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2026-03-02
基金
2023年垫江县科技局项目(djkjxm2023shmskjcxyw010)
作者信息
    1a.重庆中医药学院附属垫江医院门诊部,重庆 408300
    1b.重庆中医药学院附属垫江医院护理部,重庆 408300
    1c.重庆中医药学院附属垫江医院胸心血管乳腺外科,重庆 408300
    2.湖北医药学院基础医学院,湖北 十堰 442000
    3.重庆市垫江县人民医院肿瘤科,重庆 408300

通讯作者:

李应强,副主任医师,研究方向:肿瘤诊治。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.07.016
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏